QA: Biofrontera Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001858685_2025_Biofrontera_Inc.pdf

Logs

warning Large missing amount for aggregate "Expenses" added to remainder. industry.us_generic {'missing_ratio': 24.84225485551871, 'aggregate_val': 54553000, 'exp_sum': 2111000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'ResearchAndDevelopmentExpense': 2089000, 'remainder_Expenses': 22000}}

Graph

Absolute values for 0001858685, Biofrontera Inc

  xvar xval
0 AssetsCurrent 20,700,000
1 IntangibleAssetsNetIncludingGoodwill 35,000
2 PropertyPlantAndEquipmentNet 80,000
3 remainder_Assets 1,286,000
4 LiabilitiesCurrent 12,021,000
5 LiabilitiesNoncurrent 299,000
6 remainder_Liabilities 5,348,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,140,727
9 ResearchAndDevelopmentExpense 12,149,000
10 remainder_Expenses 188,206,533
11 remainder_Revenues 38,355,904
12 remainder_NetIncome 735,167
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 22,101,000
1 Liabilities 17,668,000
2 Expenses 205,496,260
3 Revenues 38,355,904
4 StockholdersEquity 4,433,000
5 NetIncome -166,405,189
6 ComprehensiveNetIncome -166,405,189
7 BaseVar 142,178,166
8 EconomicCapitalRatiobeforeLimitedLiability -7.88
9 EconomicCapitalRatio 0.00979

Edgar->Model Mapping

Feature Distribution

Change over Time